Risk Stratification of Acute Kidney Injury

Introduction to AKI Staging

The Kidney Disease: Improving Global Outcomes (KDIGO) criteria recommend staging patients with acute kidney injury (AKI) based on serum creatinine changes and urine output, which directly predicts mortality and need for dialysis, as stated by the Kidney International journal 2
Patients with acute-on-chronic kidney disease (AoCKD) have significantly higher mortality than those with pure AKI, particularly at Stage 1 and when fulfilling the creatinine ≥3.0× baseline criterion, according to Praxis Medical Insights 1

The KDIGO classification system defines three stages of AKI: Stage 1 (serum creatinine 1.5-1.9× baseline or ≥0.3 mg/dL increase within 48 hours), Stage 2 (serum creatinine 2.0-2.9× baseline), and Stage 3 (serum creatinine ≥3.0× baseline or ≥4.0 mg/dL), as outlined by Kidney International 2
The American College of Physicians recommends using the KDIGO criteria to stage AKI, which helps predict mortality and need for dialysis 2

Advanced age is a risk factor for non-recovery from AKI, as older patients have reduced regenerative capacity, according to Kidney International 3
Higher AKI severity, such as Stage 3, has substantially worse outcomes than Stage 1, as stated by Kidney International 2
Pre-existing chronic kidney disease (CKD) is a risk factor for non-recovery from AKI, as AoCKD patients have higher mortality and lower recovery rates, according to Kidney International 2

The National Kidney Foundation recommends consulting nephrology immediately for Stage 2 or 3 AKI, persistent AKI despite initial management, severe metabolic acidosis, hyperkalemia refractory to medical management, or consideration for renal replacement therapy, as outlined by Praxis Medical Insights 1
The European Renal Association recommends preparing for urgent dialysis if the patient develops severe metabolic acidosis, refractory hyperkalemia, severe oliguria, uremic symptoms, or pulmonary edema refractory to diuretics, as stated by Praxis Medical Insights 5

The Kidney Disease: Improving Global Outcomes (KDIGO) guidelines recommend follow-up at 3 months to assess for CKD development in all AKI patients, but intensity varies by severity, as outlined by Kidney International 2
The American Society of Nephrology recommends follow-up within 1-2 weeks for Stage 3 AKI due to high risk of CKD progression, as stated by Praxis Medical Insights 1